Zobrazeno 1 - 6
of 6
pro vyhledávání: '"Mariana Rodriguez Zubieta"'
Autor:
Marco Aurelio Díaz, Mariel Fusco, Constanza Arriola Benítez, Fernando Gayet, Ludmila García, Lucia Victoria, Sebastián Jaramillo, Juan Bayo, Mariana Rodríguez Zubieta, Manglio M. Rizzo, Flavia Piccioni, Mariana Malvicini
Publikováno v:
Scientific Reports, Vol 14, Iss 1, Pp 1-14 (2024)
Abstract The success of chemotherapy regimens in patients with non-small cell lung cancer (NSCLC) could be restricted at least in part by cancer stem cells (CSC) niches within the tumor microenvironment (TME). CSC express CD133, CD44, CD47, and SOX2,
Externí odkaz:
https://doaj.org/article/d424240095834440872f9ac5c0f9945a
Autor:
María Marcela Barrio, Riad Abes, Marina Colombo, Gabriela Pizzurro, Charlotte Boix, María Paula Roberti, Emmanuelle Gélizé, Mariana Rodriguez-Zubieta, José Mordoh, Jean-Luc Teillaud
Publikováno v:
PLoS ONE, Vol 7, Iss 7, p e40311 (2012)
Dendritic cells (DC) can achieve cross-presentation of naturally-occurring tumor-associated antigens after phagocytosis and processing of dying tumor cells. They have been used in different clinical settings to vaccinate cancer patients. We have prev
Externí odkaz:
https://doaj.org/article/6063186d4c954a6191316ff2f4298ff8
Autor:
Alicia I. Bravo, Mariana Rodriguez Zubieta, José Mordoh, Myriam Alperovich, Mariana Aris, Juan Martín Arriaga, Maria Marcela Barrio, Marina Colombo, Michele Bianchini
Publikováno v:
Journal of Investigative Dermatology. 132:365-374
MART-1 and gp100 are prototypical melanoma antigen (Ag), but their clinical use as vaccines or as targets of cytotoxic lymphocytes achieved modest success. Possible explanations could be that as MART-1 and gp100 are melanocyte differentiation Ag, clo
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::74f30814bc09da7196c672614d69d775
https://doi.org/10.1038/jid.2011.312
https://doi.org/10.1038/jid.2011.312
Autor:
Marcela Barrio, David Furman, Mariana Rodriguez Zubieta, José Mordoh, Enzo Domenichini, Alicia I. Bravo
Publikováno v:
The American Journal of Pathology. 168:1666-1675
The immune system recognizes diverse melanoma antigens. However, tumors can evade the immune response, therefore growing and progressing. It has been reported that galectin-3 and galectin-1 can induce apoptosis of activated lymphocytes. However, ther
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::bad4688289b88254b2da1bd35f40a5c9
https://doi.org/10.2353/ajpath.2006.050971
https://doi.org/10.2353/ajpath.2006.050971
Autor:
Jean-Luc Teillaud, Mariana Rodriguez-Zubieta, Marina Colombo, Gabriela Andrea Pizzurro, Riad Abès, Maria Marcela Barrio, Charlotte Boix, José Mordoh, María Paula Roberti, Emmanuelle Gélizé
Publikováno v:
PLoS ONE, Vol 7, Iss 7, p e40311 (2012)
PLoS ONE
PLoS ONE
Dendritic cells (DC) can achieve cross-presentation of naturally-occurring tumor-associated antigens after phagocytosis and processing of dying tumor cells. They have been used in different clinical settings to vaccinate cancer patients. We have prev
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::d15097f8a5e17043e8aa92df44859b6c
https://doi.org/10.1371/journal.pone.0040311
https://doi.org/10.1371/journal.pone.0040311
Autor:
Myriam Alperovich, Marina Colombo, Jose Mordoh, Mariana Rodriguez Zubieta, Maria Marcela Barrio, Mariana Aris, Juan Martín Arriaga, Alicia I. Bravo, Michele Bianchini
Publikováno v:
Cancer Research. 71:B43-B43
Background and objectives: Cutaneous melanoma (CM) is the neoplasia with the fastest growing incidence worldwide. When CM metastasizes, only a minority of patients may be cured. However, CM is an immunogenic tumor. MART-1 and gp100 are prototypical m
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::22d098daca88b698e9b7d1842e4ca959
https://doi.org/10.1158/1538-7445.fbcr11-b43
https://doi.org/10.1158/1538-7445.fbcr11-b43